P68400 (CSK21_HUMAN) Homo sapiens (Human)

Casein kinase II subunit alpha UniProtKBInterProSTRINGInteractive Modelling

391 aa; Sequence (Fasta) ; (Isoform 2); 64 identical sequences

Available Structures

257 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal Structure of Human Protein Kinase CK2 Holoenzyme Heteromer
P67870;
2-337
100PO4;ANP;ZN;
Crystal Structure of the CK2 Tetrameric Holoenzyme Heteromer
P67870;
2-335
99.7ZN;
Crystal Structure of full-length symmetric CK2 holoenzyme Heteromer
P67870;
2-333
100ZN;
Crystal structure of a heterotetrameric CK2 holoenzyme complex carrying the Andante-mutation in CK2… Heteromer
P67870;
2-333
100MG;ACP;GOL;ZN;
Crystal Structure of full-length symmetric CK2 holoenzyme with mutated alpha subunit (F121E) Heteromer
P67870;
2-333
99.7ZN;
Crystal Structure of symmetric CK2 holoenzyme with mutated alpha subunit (F121E truncated at aa 336) Heteromer
P67870;
2-330
99.7ZN;
Structure of an O-GlcNAc transferase point mutant, D554N in complex with peptide Heteromer
O15294;
339-352
92.86UDP;SO4;NAG;
Crystal structure of human O-GlcNAc Transferase in complex with UDP and a glycopeptide Heteromer
O15294;
340-352
100UDP;NAG;SO4;
Crystal structure of human O-GlcNAc Transferase with UDP-5SGlcNAc and a peptide substrate Heteromer
O15294;
340-352
10012V;SO4;
A Neutral Diphosphate Mimic Crosslinks the Active Site of Human O-GlcNAc Transferase Heteromer
O15294;
340-352
100UDP;FOR;SO4;
Crystal structure of human O-GlcNAc Transferase with UDP and a thioglycopeptide Heteromer
O15294;
340-352
100UDP;SO4;0YT;
Structure of human O-GlcNAc transferase and its complex with a peptide substrate Heteromer
O15294;
340-352
100UDP;SO4;
Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase Heteromer
O15294;
339-350
91.67UDP;9C1;
O-GlcNAc Transferase in complex with covalent inhibitor Heteromer
O15294;
339-350
91.67HQV;
Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase Heteromer
O15294;
339-350
91.67UDP;9C1;9CD;
Crystal structure of protein kinase CK2 catalytic subunit in complex with a Dibromo Dihydro Dibenzo…homo-2-mer2-331
100EDO;WJE;SO4;
The crystal structure of CK2alpha in complex with compound 30homo-2-mer2-328
99.69ACT;AQW;PO4;
The crystal structure of CK2alpha in complex with compound 25homo-2-mer2-328
99.69ACT;AOW;PO4;PEG;
The crystal structure of CK2alpha in complex with an analogue of compound 22homo-2-mer2-328
99.69ACT;DMS;AT8;
The crystal structure of CK2alpha in complex with compound 22homo-2-mer2-328
99.69ACT;AWN;PO4;
The crystal structure of CK2alpha in complex with compound 21homo-2-mer2-328
99.69ACT;AVK;
The crystal structure of CK2alpha in complex with compound 29homo-2-mer3-328
99.69ACT;AQT;PO4;PEG;DMS;
The crystal structure of CK2alpha in complex with compound 24homo-2-mer3-328
99.69ACT;AWK;PO4;PEG;
The crystal structure of CK2alpha in complex with compound 26homo-2-mer3-328
99.69ACT;PO4;DMS;AQ8;
Crystal structure of CK2alpha bound to CAM4066homo-2-mer3-327
99.69ACT;54S;DMS;PO4;
The crystal structure of CK2alpha in complex with compound 3homo-2-mer3-327
99.69MG;ADP;A4Q;IHP;
The crystal structure of CK2alpha in complex with compound 6homo-2-mer4-327
99.69ADP;MG;A4T;CL;PO4;
The crystal structure of CK2alpha in complex with compound 5homo-2-mer4-327
99.69ADP;ACT;A4B;MG;IHP;CL;
Crystal structure of human CK2amonomer2-335
100NIO; 19×EDO;
Crystal structure of CK2alphamonomer2-335
10011×EDO;
Crystal structure of a mutant of human protein kinase CK2alpha with altered cosubstrate specificitymonomer2-335
99.4CL;ANP;GOL;
Crystal structure of the CK2a1-go289 complexmonomer2-335
1009NX;NA; 26×EDO;
Crystal structure of CK2a1 complexed with KY49monomer2-335
100Y49;
Crystal structure of CK2a1 complexed with AG1112monomer2-335
1008BH;
Crystal structure of CK2a1 V116I with hemateinmonomer2-335
99.7EDO;E3U;
Crystal structure of the CK2alpha/compound10 complexmonomer2-335
100LCT;
LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA) IN COMPLEX WITH THE I…monomer2-335
1009YE;SO4;NA;
Crystal structure of human protein kinase CK2alpha (CSNK2A1 gene product) in complex with the ATP-c…monomer2-335
100QWN;SO4;
High-salt structure of protein kinase CK2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (FLC…monomer2-335
1003G5;CL;
Human CSNK2A1 bound to ERB-041monomer2-335
100041;
Crystal structure of CK2a1 H115Y with hemateinmonomer2-335
99.7E3U;
Structure of human CK2alpha in complex with the ATP-competitive inhibitor 3-(4,5,6,7-tetrabromo-1H-…monomer2-335
1004B0;SO4;CL;
Inactive conformation of human protein kinase CK2 catalytic subunitmonomer2-335
100GOL;SO4;CL;
High salt structure of human protein kinase CK2alpha in complex with 3-aminopropyl-4,5,6,7-tetrabro…monomer2-335
100B0K;CL;
Crystal structure of CK2a1 H115Y/V116I with hemateinmonomer2-335
99.4E3U;
Crystal structure of human CK2a with AMPPNPmonomer2-335
100MG;ANP;EDO;
Crystal structure of human protein kinase CK2alpha (CSNK2A1 gene product) in complex with the ATP-c…monomer2-335
100QWW;GOL;SO4;
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,6-DIBROMOBENZOTRIAZO…monomer2-334
100NL2;CL;NA;PEG;
Crystal structure of the catalytic subunit of human protein kinase CK2 with 5,6-dichloro-1-beta-D-r…monomer2-334
100RFZ; 14×CL;
HIGH-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA/CSKN2A1 GENE PRODUCT)…monomer3-335
100CL;FXB;NA;
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,7-DIBROMOBENZOTRIAZO…monomer2-334
100NKE;NA;CL;
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5-BROMOBENZOTRIAZOLEmonomer2-334
100NKW;CL;NA;
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5,6-TRIBROMOBENZOTRI…monomer2-334
100NKB;NA;CL;
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4-BROMOBENZOTRIAZOLEmonomer2-334
100NKZ;CL;
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5-DIBROMOBENZOTRIAZO…monomer2-334
100NKT;NA;
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5,6,7-TETRABROMOBENZ…monomer2-334
100TBS;PEG;NA;CL;
HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOTRIAZO…monomer2-334
1007M0;FLC;FMT;
Crystal structure of human protein kinase CK2alpha (CSNK2A1 gene product) in complex with the ATP-c…monomer2-334
100GOL;QXW;SO4;
H. SAPIENS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6,7,8-TETRABROM…monomer2-334
100TBS;CL;PEG;
H. SAPIENS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOT…monomer2-334
1007M0;CL;PEG;PG4;PGE;
Complex structure of human protein kinase CK2 catalytic subunit crystallized in the presence of a b…monomer2-334
100CL;
H. SAPIENS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOT…monomer2-334
1007M0;FLC;PEG;
Low-salt structure of protein kinase CK2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (FLC2…monomer2-334
1003G5;
Structure of protein kinase CK2alpha mutant K198R associated with the Okur-Chung Neurodevelopmental…monomer2-333
99.7EDO;SO4;CL;
Structure of protein kinase ck2 catalytic subunit (csnk2a1 gene product) in complex with the bivale…monomer2-333
100SO4;RXE;42J;
LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA; CSNK2A1 gene product)…monomer2-333
100EDO;CL;SO4;FXB;
HIGH-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA) IN COMPLEX WITH THE …monomer2-333
1009YE;CL;
Crystal structure of human CK2 alpha in complex with Quinalizarin at pH 6.5monomer2-333
100SO4;TXQ;EDO;
Crystal structure of human CK2 alpha complexed with Ellagic acidmonomer1-332
100REF;
Tetragonal structure of human protein kinase CK2 catalytic subunit in complex with a heparin oligo …monomer2-333
100IDS;GOL;SO4;
H. SAPIENS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOT…monomer3-334
1007M0;
Crystal structure of CK2alpha with pyradine derivativemonomer1-332
100ATK;
Crystal structure of human protein kinase CK2alpha (CSNK2A1 gene product) in complex with the 2-ami…monomer2-332
100N4N;SO4;
CK2alpha in complex with NMR154monomer4-334
1001KP;CL;
Crystal structure of CK2a1 H160A with hemateinmonomer2-332
99.7E3U;
Crystal structure of CK2monomer2-332
100SO4; 12×EDO;75E;
Crystal structure of CK2monomer2-332
100SO4; 14×EDO;6XT;
Crystal structure of CK2 with compound 7hmonomer2-332
100SO4; 14×EDO;5Y3;
Crystal structure of CK2alpha with pyradine derivertivemonomer2-332
100CCK;
Structure of human protein kinase CK2 catalytic subunit in complex with a CK2beta-competitive cycli…monomer2-332
100GOL;CL;
Complex structure of human protein kinase CK2 catalytic subunit with the inhibitor 4'-carboxy-6,8-c…monomer3-333
1007FC;CL;
Crystal structure of CK2monomer2-332
100.0SO4; 16×EDO;6XK;
Low salt structure of human protein kinase CK2alpha in complex with 3-aminopropyl-4,5,6,7-tetrabrom…monomer2-332
100B0K;SO4;
Crystal structure of CK2 bound by compound 7monomer2-332
100SO4;S92; 11×EDO;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with allosteric ligand…monomer3-333
100SO4;A1H6F;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with 5-((3-(4H-1,2,4-t…monomer2-332
100SO4;WAP;EDO;
CK2 alpha bound to Macrocyclemonomer3-333
100SO4;PQ5;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with 5-((2-(4H-1,2,4-t…monomer2-332
100SO4;WAU;
Crystal structure of CK2 bound by compound 9monomer2-332
100SO4; 12×EDO;S8W;
Crystal Structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunitmonomer2-332
100CL;ANP;
Crystal structure of the protein kinase CK2 catalytic subunit in complex with pyrazolo-pyrimidine m…monomer2-332
100SO4;EDO;8GQ;
Crystal structure of CK2 with compound 2monomer2-332
100SO4;EDO;5Y2;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with 4-(6-((5-isopropo…monomer2-332
100SO4;X59;
Tetragonal Complex Structure of Protein Kinase CK2 Catalytic Subunit with a Benzotriazole-Based Inh…monomer2-332
100JRJ;SO4;CL;GOL;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with TR06772818monomer3-333
100SO4;A1IG6;
Human CK2 catalytic domain in complex with CX-4945monomer2-332
1003NG;SO4;
CK2 alpha bound to unclosed Macrocyclemonomer3-333
100SO4;PQ8;
Crystal structure of the CK2alpha/compound3 complexmonomer2-332
100LCD;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with allosteric ligand…monomer2-332
100SO4;EDO;A1H6J;
Structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit with the AT…monomer2-332
100SO4;04G;GOL;CL;
Complex structure of human protein kinase CK2 catalytic subunit with the inhibitor 4'-carboxy-6,8-c…monomer2-331
1007FC;GOL;CL;
Human CK2 catalytic domain in complex with a difurane derivative inhibitor (AMR)monomer2-331
10014I;SO4;
Human CK2 catalytic domain in complex with a benzopyridoindole derivative inhibitormonomer2-331
10018E;SO4;
Human CK2 catalytic domain in complex with a benzopyridoindole derivative inhibitormonomer2-331
10019E;SO4;
CK2 alpha bound to chemical probe SGC-CK2-1monomer3-332
100.0SO4;QBE;PEG;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with 5-((4-((2-aminoet…monomer3-332
10010×SO4;A1H8C;
Crystal structure of human CK2 alpha in complex with emodin at pH 6.5monomer2-331
100EMO;EDO;7PE;SO4;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with allosteric compou…monomer2-331
100SO4;EDO;FW3;NA;
Crystal structure of the apo-form of human CK2 alpha at pH 6.5monomer2-331
100SO4;EDO;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with allosteric compou…monomer2-331
100FWU;SO4;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with 4-(6-(6-isopropox…monomer3-332
100SO4;X5E;
Crystal Structure of Human CK2-alpha in complex with a benzimidazole inhibitor (K164) at 1.25 A res…monomer2-330
100SO4;EDO;EXX;PGE;PEG;DMS;
Monoclinic structure of human protein kinase CK2 catalytic subunit in complex with a heparin oligo …monomer2-330
100IDS;GOL;NIO;
Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 1monomer2-330
100SO4;EDO;JWQ;
Crystal structure of human Protein kinase CK2 catalytic subunit in complex with the ATP-competitive…monomer2-330
1008QK;ACT;GOL;
Human CK2 catalytic domain in complex with a difurane derivative inhibitor (CPA)monomer3-331
10001I;SO4;
Crystal structure of human Protein kinase CK2 catalytic subunit in complex with the ATP-competitive…monomer2-330
1008QH;ACT;GOL;
Crystal structure of human Protein kinase CK2 catalytic subunit in complex with the ATP-competitive…monomer2-330
100KC5;ACT;GOL;
Crystal structure of human CK2alpha in complex with the ATP-competitive inhibitor 4-[(E)-(fluoren-9…monomer2-330
100GOL;E91;
Crystal structure of CK2a1 with hemateinmonomer2-330
100E3U;
Complex structure of human protein kinase CK2 catalytic subunit with a thieno[2,3-d]pyrimidin inhib…monomer3-331
1007EY;CL;GOL;
Structure of protein kinase CK2 catalytic subunit in complex with the CK2beta-competitive bisubstra…monomer2-330
1009AB;
Casein Kinase II bound to Inhibitormonomer2-330
1000Y4;CL;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with allosteric ligand…monomer2-330
100SO4;EDO;A1H6H;
Crystal structure of the CK2a/benzoic acid derivative complexmonomer2-330
100HCK;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with Leucettinib-92monomer2-330
100SO4;WAK;
Crystal structure of human CK2alpha complexed with a potent inhibitormonomer2-330
100TID;
CK2 kinase bound to inhibitor AB668monomer3-331
100SO4;TL0;GOL;
CK2 alpha bound to chemical probe SGC-CK2-1 derivativemonomer3-331
100.0SO4;QB8;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with allosteric ligand…monomer3-331
100SO4;EDO;A1H6E;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with allosteric ligand…monomer2-330
100SO4;EDO;A1H6G;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with allosteric ligand…monomer3-331
100SO4;EDO;A1H6I;
Complex structure of human protein kinase CK2 catalytic subunit with a thieno[2,3-d]pyrimidin inhib…monomer3-331
1007EY;CL;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with compound 2 (AA-CS…monomer3-331
100.0SO4;QIA;
Crystal structure of P8C9 bound to CK2alphamonomer2-329
100ADP;ACT;GOL;MG;PEG;SO4;NA;
Crystal structure of P7C8 bound to CK2alphamonomer2-329
100ADP;GOL;MG;SO4;OUT;
Human protein kinase CK2 alpha in complex with ferulic aldehydemonomer3-330
100SO4;CIY;EDO;
High pH-value crystal structure of emodin in complex with the catalytic subunit of protein kinase C…monomer3-330
100CL;EMO;
Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 4monomer3-330
100EDO;K0Z;SO4;
Human protein kinase CK2 alpha in complex with ferulic acidmonomer3-330
100SO4;FER;EDO;
Human protein kinase CK2 alpha in complex with curcumin degradation productsmonomer3-330
100SO4;EDO;FER;V55;GJK;CIY;
Crystal structure of the catalytic subunit of protein kinase CK2 (C-terminal deletion mutant 1-335)…monomer2-329
100SO4;ANP;
Human protein kinase CK2 alpha in complex with boldinemonomer3-330
100GHT;SO4;EDO;
Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 3monomer3-330
100EDO;K0N;SO4;
Crystal structure of human CK2 alpha in complex with emodin at pH 8.5monomer3-330
100EMO;SO4;
Crystal structure of CK2alpha with 2-hydroxy-5-methylbenzoic acid and (methyl 4-((3-(3-chloro-4-(ph…monomer2-329
99.69551;54G;PO4;ACT;
Crystal structure of CK2alpha with (methyl 4-((3-(3-chloro-4-(phenyl)benzylamino)propyl)amino)-4-ox…monomer2-329
99.69ACT;551;PO4;
Crystal structure of the apo-form of human CK2 alpha at pH 8.5monomer3-330
100SO4;EDO;
Human protein kinase CK2 alpha in complex with vanillinmonomer3-330
100SO4;V55;
Structure of human CK2 alpha kinase (catalytic subunit) with the inhibitor 108600.monomer3-330
100SO4;GOL;ON6;
Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 7monomer3-330
100K1B;EDO;SO4;
Human protein kinase CK2 alpha in complex with CK2-TN01monomer3-330
100EDO;TO6;SO4;
Human protein kinase CK2 alpha in complex with CK2-TN02monomer3-330
100TNO;SO4;
Human protein kinase CK2 alpha in complex with feruloylmethanemonomer3-330
100GJK;SO4;EDO;
Human CK2 catalytic domain in complex with a pyridocarbazole derivative inhibitormonomer3-330
1001EL;
The crystal structure of CK2alpha in complex with compound 7monomer2-329
98.78ACT;ADP;MG;A9K;PO4;
Low pH-value crystal structure of emodin in complex with the catalytic subunit of protein kinase CK2monomer3-330
100CL;EMO;
Human protein kinase CK2 alpha in complex with coumestrolmonomer3-330
100CUE;SO4;
The crystal structure of CK2alpha in complex with compound 20monomer2-329
99.69ACT;AW5;AVZ;
Human protein kinase CK2 alpha in complex with CK2-TN03monomer3-330
100TN0;SO4;
Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 14monomer3-330
100JYZ;SO4;
Crystal structure of CK2alpha with ZT0627 boundmonomer2-329
98.78HBD;ACT;
Monoclinic Complex Structure of Protein Kinase CK2 Catalytic Subunit with a Benzotriazole-Based Inh…monomer2-329
100JRJ;SO4;GOL;
Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with allosteric ligand…monomer3-330
100.0SO4;A1H6D;
X-ray structure of protein kinase ck2 alpha subunit in D2Omonomer3-329
99.39SO4;
Structure of Compound 17 bound to CK2alphamonomer3-329
98.78ATP;ACT;LW3;PO4;
Crystal structure of P8C9 bound to CK2alphamonomer3-329
99.69MG;ADP;GOL;NA;
X-ray structure of protein kinase ck2 alpha subunit H148A mutantmonomer3-329
99.07SO4;
The strucuture of Compound 15 bound to CK2alphamonomer3-329
98.78GOL;ACT;LVU;ADP;MG;
Human CK2 catalytic domain in complex with AMPPNmonomer2-328
100GOL;SO4;MG;ANP;
The Crystal structure of RO4493940 bound to CK2alphamonomer3-329
98.78R7W;EPE;ACT;NA;
Compound 9 Bound to CK2alphamonomer3-329
98.78ADP;KEC;ACT;
The crystal structure of CK2alpha in complex with compound 9monomer3-329
98.78ACT;AWE;TFA;
Crystal Structure of CK2alphamonomer3-329
98.78ATP;ACT;
Crystal Structure of CK2alpha with Compound 6 boundmonomer3-329
98.78ACT;GAB;
The crystal structure of CK2alpha in complex with compound 33monomer3-329
98.78ACT;AUH;
The crystal structure of CK2alpha in complex with CAM4712 and compound 37monomer3-329
98.78ACT;AUW;54G;
Structure of Compound 6 Bound to CK2alphamonomer3-329
98.78ACT;ATP;KD6;
The Crystal structure of RO4613269 bound to CK2alphamonomer3-329
98.78QY2;
Crystal structure of compound 7 bound to CK2alphamonomer3-329
98.78KC0;ADP;
The Crystal structure of CK2a bound to P2-C4monomer3-329
99.69GOL;BEZ;ACT;A1H27;
The crystal structure of CK2alpha in complex with compound 1monomer3-329
98.78ACT;TFA;AUT;
The Crystal structure of GW8695 bound to CK2alphamonomer3-329
98.78QXZ;
The Structure of CK2alpha with CCh503 boundmonomer3-329
98.78503;ATP;
The crystal structure of CK2alpha in complex with CAM4712monomer3-329
98.78ACT;TFA;AUW;
Crystal Structure of CK2alpha with Compound 5 boundmonomer3-329
98.7854G;ACT;
X-ray structure of protein kinase ck2 alpha subunit H148S mutantmonomer3-329
99.07SO4;
Crystal Structure of CK2alpha with Compound 2 bound to second crystal formmonomer3-329
98.78N5Q;ACT;
Crystal structure of compound 7 bound to CK2alphamonomer3-329
98.78ATP;ACT;H4N;
The crystal structure of CK2alpha in complex with compound 14monomer3-329
98.78ACT;AU8;ATP;
The crystal structure of CK2alpha in complex with compound 31monomer3-329
98.78B4Q;ACT;
The crystal structure of CK2alpha in complex with compound 11monomer3-329
98.78ACT;DMS;J27;ATP;
Crystal structure of CK2alpha bound to CAM4066monomer3-329
98.78ACT;54S;
The crystal structure of CK2alpha in complex with an analogue of compound 1monomer3-329
98.78ACT;ATP;AFK;
Compound 9 Bound to CK2alphamonomer3-329
98.78ATP;ACT;KEX;
The crystal structure of CK2alpha in complex with compound 27monomer3-329
98.78ACT;AOK;
Structure of protein kinase CK2 catalytic subunit with the CK2beta-competitive bisubstrate inhibito…monomer3-329
100NA;A0Z;
The Structure of CK2alpha with CCh507 boundmonomer3-329
98.78E8K;ATP;
Structure of Belumosudil bound to CK2alphamonomer3-329
98.78ACT;ICQ;PO4;
Structure of Compound 13 bound to CK2alphamonomer3-329
98.78ACT;LVF;ATP;
Crystal structure of human protein kinase CK2 alpha subunit in complex with the inhibitor CX-4945monomer3-329
1003NG;SO4;
The crystal structure of CK2alpha in complex with analogues of compound 1monomer3-329
98.78ACT;AFW;
Crystal Structure of CK2alpha with Compound 5 boundmonomer3-329
99.3954Z;ATP;ACT;
Crystal Structure of CK2alpha with Compound 1 boundmonomer3-329
98.78ACT;P5W;
Structure of Compound 14 bound to CK2alphamonomer3-329
98.78LVL;ATP;ACT;
X-ray structure of protein kinase ck2 alpha subunit H148N mutantmonomer3-329
99.08SO4;
Crystal Structure of CK2alpha with 3,4-dichlorophenethylamine boundmonomer3-329
99.6942J;ACT;
X-ray structure of protein kinase ck2 alpha subunit H148A mutantmonomer3-329
100SO4;
The Crystal structure of CK2a bound to P1-C4monomer3-329
99.69BEZ;A1H27;
Crystal structure of human protein kinase CK2 alpha subunit in complex with the inhibitor CX-5279monomer3-329
100FU9;SO4;PEG;EDO;
Crystal structure of CK2a1 with 5-iodotubercidinmonomer2-328
1005ID;EDO;
Crystal Structure of CK2alpha with GTP boundmonomer3-329
98.78GDP;
Crystal structure of human CK2 alpha in complex with Quinalizarin at pH 8.5monomer3-329
100TXQ;SO4;
Crystal Structure of CK2alphamonomer2-328
99.69ADP;IHP;MG;ACT;
Compound 20 Bound to CK2alphamonomer3-329
98.78ATP;ACT;KF6;
Crystal Structure of CK2alpha with Compound 3 boundmonomer2-328
99.69ACT;K82;PO4;
Crystal structure of human protein kinase CK2 in complex with the inhibitor CX-5011monomer3-329
100E1B;SO4;
The crystal structure of CK2alpha in complex with an analogue of compound 22monomer3-329
98.78AU2;
The crystal structure of CK2alpha in complex with an analogue of compound 1monomer3-329
98.78ATP;ACT;A9W;
The crystal structure of CK2alpha in complex with compound 19monomer2-328
99.69ACT;AJK;PO4;
The crystal structure of CK2alpha in complex with compound 32monomer3-329
98.78B5E;ACT;
Crystal Structure of CK2alpha with CAM187 boundmonomer3-329
98.77ACT;EZN;
The crystal structure of CK2alpha in complex with compound 23monomer3-329
98.78ACT;AHK;
Crystal Structure of CK2alpha with N-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methan…monomer2-328
99.69PO4;YRA;
Casein kinase 2 (CK2) bound to inhibitormonomer2-328
100CL;0XG;
Crystal structure of CK2alpha with 2-hydroxy-5-methylbenzoic acid and N-(3-(3-chloro-4-(phenyl)benz…monomer2-328
99.6954R;54G;ACT;
Casein kinase 2 in complex with AZ-Inhibitormonomer2-328
100LNH;CL;
Crystal structure of human CK2 alpha complexed with apigeninmonomer2-328
100.0AGI;EDO;
Joint X-ray/neutron structure of protein kinase ck2 alpha subunitmonomer3-329
99.39SO4;
Crystal Structure of CK2alpha with a novel closed conformation of the aD loopmonomer4-329
99.69ACT;
Crystal structure of CK2alpha with ZT0583 bound.monomer3-328
98.77YTX;ACT;
Crystal Structure of CK2alpha with 2 molecules of ADP boundmonomer2-327
100ADP;ACT;MG;PO4;
Crystal Structure of CK2alpha with Compound 2 boundmonomer2-327
100N5Q;
Crystal structure of compound 2 bound to CK2alphamonomer2-327
99.691NP;
Crystal Structure of CK2alpha with ZT0432 boundmonomer2-327
99.69BR9;ACT;
The crystal structure of CK2alpha in complex with compound 18monomer2-327
99.69ACT;PO4;B5W;
Crystal Structure of CK2alpha with Compound 7 boundmonomer3-328
99.69JMB;ACT;
Crystal Structure of CK2alpha with N-((2-chloro-[1,1'-biphenyl]-4-yl)methyl)butane-1,4-diamine boundmonomer3-328
99.69H83;ACT;
Crystal structure of CK2 with compound 7bmonomer3-328
100.0CL; 18×EDO;5Y4;
Crystal structure of CK2alpha with 3-(3-chloro-4-(phenyl)benzylamino)propan-1-ol boundmonomer3-328
99.69ACT;54P;
Crystal Structure of CK2alpha with N-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methan…monomer2-327
99.69ACT;4IH;PO4;
1-(2-chloro-[1,1'-biphenyl]-4-yl)-N-methylethanaminemonomer3-328
99.69ADP;IHP;J2P;
Crystal structure of the catalytic subunit of human protein kinase CK2monomer4-329
99.39
Crystal structure of human CK2 in complex with inositol hexakisphosphatemonomer4-329
99.69
The crystal structure of CK2alpha in complex with compound 4monomer3-327
99.69ACT;A8Q;ATP;
The crystal structure of CK2alpha in complex with compound 3monomer3-327
99.69ACT;A8Q;ATP;
Crystal Structure of CK2alpha with N-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methan…monomer4-328
99.69ACT;C98;PO4;
Crystal structure of compound 2 bound to CK2alphamonomer3-327
99.69PO4;
Crystal Structure of CK2alpha with N-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methan…monomer3-327
99.69ADP;MG;IHP;ACT;OQC;PO4;
Crystal Structure of CK2alpha with ZT0432 boundmonomer3-327
99.69PO4;ADP;ACT;RKN;MG;
Crystal structure of Ck2alpha with ZT0633 boundmonomer3-327
98.77HC4;
Crystal Structure of CK2alpha with Compound 4 boundmonomer4-327
99.6954E;ATP;
The crystal structure of CK2alpha in complex with compound 2monomer4-327
99.69A4N;
Crystal Structure of CK2alpha with N-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methan…monomer4-327
99.69
Crystal structure of CK2alpha with N-(3-(3-chloro-4-(phenyl)benzylamino)propyl)acetamide boundmonomer4-327
99.69ACT;54R;
Crystal Structure of CK2alpha with N-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methan…monomer4-327
99.69ACT;
Structure of a chimeric construct of human CK2alpha and human CK2alpha' in complex with a non-hydro…monomer2-325
100ANP;MG;CL;SO4;GOL;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5oni.2.Amonomer0.902-335
9YE;100.00

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 25oni.2.Amonomer0.881-199
100.00